Plaza Accord
The Plaza Accord was an agreement signed between the US, Japan, West Germany, France and the UK at the Plaza Hotel in New York in 1985.
During the early 1980s, the value of the US dollar rose significantly against those of its major trading partners. The Ronald Reagan government was looking to reduce the rate of inflation, which led the US Federal Reserve to increase US interest rates sharply. As a result, more people bought dollars to take advantage of the higher interest rates on offer, pushing up its value.
This created problems for US businesses the high dollar made their goods more expensive on world markets, while making imports cheaper in America. Some companies began lobbying politicians to shield them from foreign rivals.
To avoid a trade war, the US, Japan, West Germany, France and the UK signed an agreement at the Plaza Hotel in New York in 1985 the Plaza Accord. They agreed to intervene in the currency markets to drive down the value of the dollar, by selling dollars. It worked the dollar fell in value by 50% over the next two years.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Unfortunately for Japan, the falling dollar and rising yen hammered its exports. To boost its economy, Japan cut interest rates, which led to a credit boom and a price bubble in the Japanese stock and property markets. The bubble burst in 1990, and the Japanese economy has not yet recovered.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published